Resumen del estudio
(ESS), and Fatigue Severity Scale (FSS)-along with serum cortisol, triglycerides, LDL, and blood pressure measurements. Ashwagen® significantly reduced anxiety and stress markers compared with placebo. HAM-A, GAD-7, and PSS scores decreased by 26.94%, 50.77%, and 30.47%, respectively, in the Ashwagen® group. Cortisol levels declined by 28.99% and triglycerides by 13.00%, with favorable trends in LDL and blood pressure. No serious adverse events were reported. Ashwagen® was found to be a safe and effective adjunctive integrative intervention for stress and anxiety management in patients with pre-existing
Detalles bibliográficos
- Autores: Pattojoshi A, Kumar Patra S, Idrees SA, Behera S, Dalua SS, Tiwari P
- Publicado en: Stress (Amsterdam, Netherlands)
- Fecha: 2026 Dec 31
- PMID: 42105298
- DOI: 10.1080/10253890.2026.2669544
📖 Leer el estudio completo en PubMed →
Esta evidencia se ha indexado automáticamente desde la base de datos PubMed (NCBI/NLM, US National Institutes of Health). El resumen mostrado es propiedad intelectual de sus autores y editorial.
